Author: Hattan D.
Publisher: Academic Press
ISSN: 0273-2300
Source: Regulatory Toxicology and Pharmacology, Vol.24, Iss.3, 1996-12, pp. : 232-235
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
More funds requested for US FDA's safety initiatives
Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. :
The US Public Citizen group has requested that the FDA remove leflunomide [`Arava']
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
FDA grants priority review for prasugrel
Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. :